Regulatory Record: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company

FDA action counts

Enforcement history

On 2026-09-30, Argus HQ recorded an FDA recall for Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, rated "high" severity in Argus HQ's classification: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company — Class II recall: Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%,…. On 2026-09-30, Argus HQ recorded an FDA recall for Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, rated "high" severity in Argus HQ's classification: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company — Class II recall: Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%,…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company has 2 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event.

Frequently asked questions

What is the most recent FDA action on file for Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company?

September 30, 2026. Argus HQ ingests new FDA enforcement records daily.

Has Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company had product recalls?

Yes, 2 recalls on file. See the full history below for each one.

Is this FDA enforcement data for Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company had?

Argus HQ has recorded 2 FDA events for Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company: 0 warning letters, 2 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Related enforcement actions

• Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company — Class II recall: Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%,… →
• Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company — Class II recall: Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%,… →

Compare with

• Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company vs Medline Industries, LP
• Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company vs Philips North America
• Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company vs Boston Scientific Corporation
• Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company vs Baxter Healthcare Corporation
• Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.